The STarT Back Trial Study Protocol http://t.co/8QpI2U4Sw5
Mgmt includes treatment to reduce disability related to future episodes of low back pain. http://t.co/3AfnRE9qXB
85% of LBP consulters have non-specific LBP & treatment depends on the providers' preferences & clinical experience http://t.co/3AfnRE9qXB
85% of LBP consulters have non-specific LBP & treatment depends on the providers' preferences & clinical experience http://t.co/3AfnRE9qXB
treatments are not reaching appropriate patient groups http://t.co/3AfnRE9qXB
Patients are classified as "low risk" of future disabling LBP if they score positively on fewer than 4 questions http://t.co/3AfnRE9qXB
we have developed targeted treatments for patients allocated to the low, medium and high-risk subgroups http://t.co/3AfnRE9qXB
Mgmt includes an assessment & differential diagnosis (particularly for patients with referred leg pain) http://t.co/3AfnRE9qXB
Patients in 'medium risk' grp present w physical indicators (disabling back pain, referred leg pain & co-morbid pain) http://t.co/3AfnRE9qXB
pain is influenced by both tissue pathology and psychological factors http://t.co/3AfnRE9qXB
Primary care guidelines for managing low back pain within a biopsychosocial framework http://t.co/3AfnRE9qXB
"Back pain is a major health problem and many sufferers develop persistent symptoms." http://t.co/3AfnRE9qXB